GlassScriptPhysician profile
Nataliya Bilan
NPI 1558870022
$1,664.81
in general payments reported to CMS, 2019-2025
15 companies · $735 in 2025
The $735 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $136 · 2023: $174 · 2024: $619 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,517 · Education: $11.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,516.91 |
| Education | $11.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $584.12 | 2023-2025 | Airsupra, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $336.76 | 2024-2025 | Nucala, Trelegy Ellipta |
| Abbvie INC. | $292.51 | 2024-2025 | |
| Allergan, INC. | $114.98 | 2022 | |
| Genzyme Corporation | $58.38 | 2025 | |
| Novartis Pharmaceuticals Corporation | $46.81 | 2025 | |
| Galderma Laboratories, L.P. | $37.95 | 2022-2023 | |
| Alk-Abello, INC | $36.90 | 2024-2025 | Grastek, Odactra, Ragwitek |
| Ars Pharmaceuticals Operations, INC. | $24.73 | 2025 | Neffy |
| Inspire Medical Systems, INC. | $24.54 | 2025 | Inspire |
| 3b Medical, INC. | $23.70 | 2025 | Luna |
| Paratek Pharmaceuticals, INC. | $22.54 | 2025 | Xhance |
| Regeneron Healthcare Solutions, INC. | $22.50 | 2025 | Dupixent |
| Ascensia Diabetes Care US INC. | $21.18 | 2023 | |
| Medtronic, INC. | $17.21 | 2023 | Nuvent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nataliya Bilan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.